1CROSBY J R, TAPPAN K A, SELFERR R A, et al. Chimera analysis reveals that fibmblasts and endothelial cells require platelet-derived growth factor receptor? expression for participation in reactive connective tissue formation in adults but not during development [ J ]. Am J Pathol, 1999, 154:1315 - 1321.
2HELDIN C H, WESTETMARK B. Mechanism of action and in vivo role of platelet - derived growth factor[ J ]. Physiol Rev, 1999, 79 (4) :1283 - 1316.
3FREDRIKSSON L, LI H, ERIKSSON U. The PDGF family: four gene products from five dimeric isoforms [ J ]. Cytokine Growth Factor Rev, 2004, 15(4) :197-204.
4WILLIAMS S M G, DISBROW G L, SCHLEGEL R, et al. Requirement of epidermal growth factor receptor for hyperplasia induced by ES, a high-risk human papillomavirus oncogenc [ J ]. Cancer Res, 2005, 65(15) : 6534 -6542.
5THOMSEN P, VAN DEURS B, NORRILD B, et al. The HPV16 E5 oncogene inhibits endocytic trafficking [J]. Oncogene, 2000, 19 (52) :6023 - 6032.
6DISBROW G L, HANOVER J A, SCHLEGEL R, et al. Endoplasmie reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not tans-Golgi pH[J]. J Virol, 2005,79(9) :5839 - 5846.
7BAGNATO A, NATALI P G. Endothelin receptors as novel targets in tumor therapy[J]. J Transl Med, 2004, 2(1):16.
8ROBERTS W G, WHALEN P M, SODERSTROM E, el al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451 [J]. Cancer Res, 2005, 65 (3) :957 - 966.
